Kristin Pulewka1,2, Daniel Wolff3, Philipp Y Herzberg4, Hildegard Greinix5, Pia Heussner6, Friederike H A Mumm6, Stephanie von Harsdorf7, Kathrin Rieger8, Philipp Hemmati8, Andreas Hochhaus2, Inken Hilgendorf9. 1. Institute of Psychosocial Medicine and Psychotherapy, University Hospital Jena, Jena, Germany. 2. Klinik für Innere Medizin II, Abteilung Hämatologie und Internistische Onkologie, Universitätsklinikum Jena, Am Klinikum 1, 07740, Jena, Germany. 3. Department of Internal Medicine III, University Hospital of Regensburg, Regensburg, Germany. 4. Personality Psychology and Psychological Assessment, Faculty of Humanities and Social Sciences, Helmut Schmidt University of the Federal Armed Forces Hamburg, Hamburg, Germany. 5. Division of Hematology, Department of Internal Medicine I, Medical University of Graz, Graz, Austria. 6. Department of Internal Medicine III, Psycho-Oncology, Klinikum Großhadern, Ludwig-Maximilians-University, Munich, Germany. 7. Department of Internal Medicine III, University of Ulm, Ulm, Germany. 8. Department of Hematology, Oncology and Tumor Immunology, Charité-University Hospital Berlin, Berlin, Germany. 9. Klinik für Innere Medizin II, Abteilung Hämatologie und Internistische Onkologie, Universitätsklinikum Jena, Am Klinikum 1, 07740, Jena, Germany. inken.hilgendorf@med.uni-jena.de.
Abstract
PURPOSE: Allogeneic hematopoietic stem-cell transplantation (alloHSCT) is physically and psychosocially demanding. Among transplant recipients, adolescent and young adults (AYA) represent a special group, as disease occurs early in life, resulting in the prospect of long survival time and high burden of alloHSCT sequelae. However, data focusing on AYA undergoing alloHSCT are rare. METHODS: Data resulting from a prospective multicenter trial initially focusing on graft-versus-host disease (GvHD) after alloHSCT were reused to analyse the differences between AYA and elderly patients. In total, data of 205 alloHSCT recipients were evaluated. Patients completed the FACT-BMT, HAP, SF-36, 24-AM, LOT-R, BSSS, HADS, and GvHD questionnaires. RESULTS: Median age of AYA and non-AYA patients was 29 and 52 years. Using 24-AM-Test, evaluating personality traits, non-AYA reported to be more conscientious (p = 0.033). However, AYA described higher quality of life regarding physical role functioning (p = 0.001), physical functioning (p = 0.002), bodily pain (p = 0.023), and emotional role function (p = 0.027) in the SF-36. General health perception, vitality, social role functioning, and mental health were comparable among both groups. On HAP scale, AYA reported higher maximum (p = 0.003) and adjusted activity scores (p = 0.002), but showed similar restrictions regarding activity, self-supply, and self-determination. CONCLUSION: AYA represent a particular group characterized by higher physical well-being and activity scores, and significantly vary from non-AYA patients in psychosocial aspects. Studies covering distinctive features of AYA undergoing alloHSCT are warranted to improve awareness of the special needs of this group.
PURPOSE: Allogeneic hematopoietic stem-cell transplantation (alloHSCT) is physically and psychosocially demanding. Among transplant recipients, adolescent and young adults (AYA) represent a special group, as disease occurs early in life, resulting in the prospect of long survival time and high burden of alloHSCT sequelae. However, data focusing on AYA undergoing alloHSCT are rare. METHODS: Data resulting from a prospective multicenter trial initially focusing on graft-versus-host disease (GvHD) after alloHSCT were reused to analyse the differences between AYA and elderly patients. In total, data of 205 alloHSCT recipients were evaluated. Patients completed the FACT-BMT, HAP, SF-36, 24-AM, LOT-R, BSSS, HADS, and GvHD questionnaires. RESULTS: Median age of AYA and non-AYA patients was 29 and 52 years. Using 24-AM-Test, evaluating personality traits, non-AYA reported to be more conscientious (p = 0.033). However, AYA described higher quality of life regarding physical role functioning (p = 0.001), physical functioning (p = 0.002), bodily pain (p = 0.023), and emotional role function (p = 0.027) in the SF-36. General health perception, vitality, social role functioning, and mental health were comparable among both groups. On HAP scale, AYA reported higher maximum (p = 0.003) and adjusted activity scores (p = 0.002), but showed similar restrictions regarding activity, self-supply, and self-determination. CONCLUSION: AYA represent a particular group characterized by higher physical well-being and activity scores, and significantly vary from non-AYA patients in psychosocial aspects. Studies covering distinctive features of AYA undergoing alloHSCT are warranted to improve awareness of the special needs of this group.
Entities:
Keywords:
Adolescents and young adults (AYA); Psycho-oncology; Quality of life; Stem-cell transplantation
Authors: Marilyn Stern; Elena Krivoy; Rebecca H Foster; Matthew Bitsko; Amos Toren; Myriam Ben-Arush Journal: Pediatr Blood Cancer Date: 2010-10 Impact factor: 3.167
Authors: Alix Edna Hall; Allison Wendy Boyes; Jennifer Bowman; Raoul A Walsh; Erica L James; Afaf Girgis Journal: Support Care Cancer Date: 2011-07-01 Impact factor: 3.603
Authors: Gavin J Dyson; Kate Thompson; Susan Palmer; David M Thomas; Penelope Schofield Journal: Support Care Cancer Date: 2011-02-11 Impact factor: 3.603
Authors: J Wiskemann; R Kuehl; P Dreger; R Schwerdtfeger; G Huber; C M Ulrich; D Jaeger; M Bohus Journal: Bone Marrow Transplant Date: 2013-12-09 Impact factor: 5.483
Authors: Casey A Walsh; Jean C Yi; Abby R Rosenberg; Marie-Laure V Crouch; Wendy M Leisenring; Karen L Syrjala Journal: Psychooncology Date: 2020-08-13 Impact factor: 3.894
Authors: Reema R Mathanda; Betty K Hamilton; Lisa Rybicki; Anjali S Advani; Amy Colver; Jane Dabney; Christina Ferraro; Rabi Hanna; Matt Kalaycio; Christine Lawrence; Linda McLellan; Ronald Sobecks; Navneet S Majhail; Seth J Rotz Journal: Biol Blood Marrow Transplant Date: 2020-05-19 Impact factor: 5.742